These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12842647)

  • 1. Cognitive behavioural therapy as a potential treatment for vasovagal/neurocardiogenic syncope--a pilot study.
    Newton JL; Kenny RA; Baker CR
    Europace; 2003 Jul; 5(3):299-301. PubMed ID: 12842647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope.
    Gracie J; Newton JL; Norton M; Baker C; Freeston M
    Europace; 2006 Aug; 8(8):636-43. PubMed ID: 16864617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the recurrent syncope episodes on neurocognitive functions in patients with vasovagal syncope.
    Jędrzejczyk-Spaho J; Pietrucha AZ; Borowiec A; Bzukała I; Wnuk M; Konduracka E; Nessler J
    Pol Merkur Lekarski; 2017 Mar; 42(249):106-109. PubMed ID: 28333901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological treatment of malignant vasovagal syncope due to bloodphobia.
    Van Dijk N; Velzeboer SC; Destrée-Vonk A; Linzer M; Wieling W
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):122-4. PubMed ID: 11227958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of closed loop stimulation pacing (CLS) in vasovagal syncope.
    Ruzieh M; Ammari Z; Dasa O; Karim S; Grubb B
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1302-1307. PubMed ID: 28895151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compression stockings for treating vasovagal syncope (COMFORTS-II) trial: Rationale and design of a triple-blind, multi-center, randomized controlled trial.
    Tavolinejad H; Poopak A; Sadeghian S; Bozorgi A; Oraii A; Mollazadeh R; Emkanjoo Z; Kiarsi M; Shahabi J; Jalali A; Alaeddini F; Ariannejad H; Yadangi S; Oraii S; Kheirkhah J; Assadianrad M; Aminorroaya A; Tajdini M
    Am Heart J; 2022 Jul; 249():57-65. PubMed ID: 35405100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of vasovagal syncope.
    Ballantyne BA; Letourneau-Shesaf S; Raj SR
    Auton Neurosci; 2021 Dec; 236():102904. PubMed ID: 34763249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasovagal (neurocardiogenic) syncope in the clinical practice.
    Kollar B; Mikes P; Siarnik P; Klobucnikova K; Krizova L; Waczulikova I
    Neuro Endocrinol Lett; 2012; 33(1):60-6. PubMed ID: 22467114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ongoing clinical trials for Vasovagal Syncope: where are we in 2014?
    Coffin ST; Raj SR
    Auton Neurosci; 2014 Sep; 184():77-82. PubMed ID: 24913692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperament and character personality dimensions in nitrate-tilt-induced vasovagal syncope patients.
    Russo V; AlTurki A; Rago A; Proietti R; Chaussé G; Monteleone AM; Scognamiglio P; Monteleone P; Nigro G
    Hellenic J Cardiol; 2017; 58(6):411-416. PubMed ID: 28212873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofeedback-assisted relaxation therapy in neurocardiogenic syncope: a pilot study.
    McGrady AV; Kern-Buell C; Bush E; Devonshire R; Claggett AL; Grubb BP
    Appl Psychophysiol Biofeedback; 2003 Sep; 28(3):183-92. PubMed ID: 12964450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial.
    Tajdini M; Aminorroaya A; Tavolinejad H; Tofighi S; Jalali A; Sadeghian S; Vasheghani-Farahani A; Yadangi S; Shahmansouri N; Akhondzadeh S; Bozorgi A
    Int J Cardiol Heart Vasc; 2021 Jun; 34():100789. PubMed ID: 34027030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applied tension treatment of vasovagal syncope during pregnancy.
    Peterson AL; Isler WC
    Mil Med; 2004 Sep; 169(9):751-3. PubMed ID: 15495734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-suited for prevention of syncope in patients with vasovagal syncope: a pilot study.
    Rasmeehirun P; Krittayaphong R
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S162-7. PubMed ID: 24772594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of sleep apnoea syndrome (SAS) in patients with vasovagal syncope (VVS): a protocol for the VVS-SAS cohort study.
    Puel V; Godard I; Papaioannou G; Gosse P; Pepin JL; Thoin F; Deharo JC; Roche F; Zarqane N; Gagnadoux F; Suehs CM; Molinari N
    BMJ Open; 2020 Sep; 10(9):e038791. PubMed ID: 32998925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Level of psychosocial impairment predicts early response to treatment in vasovagal syncope.
    Flint B; Baker C; Freeston M; Newton JL
    Europace; 2009 Feb; 11(2):231-6. PubMed ID: 19059994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological correlates of vasovagal versus medically unexplained syncope.
    Rafanelli C; Gostoli S; Roncuzzi R; Sassone B
    Gen Hosp Psychiatry; 2013; 35(3):246-52. PubMed ID: 23415579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technical options of electrotherapy in patients with vasovagal syncope].
    Bałczewska D; Kaczmarek K; Ptaszyński P; Wranicz JK; Cygankiewicz I
    Pol Merkur Lekarski; 2016 Oct; 41(244):177-179. PubMed ID: 27760090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between blood routine test parameters and syncopal recurrence of vasovagal syncope in children].
    Song JY; Li HX; Li XY; Wang YL; Jin HF; Du JB
    Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):59-63. PubMed ID: 28072962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.